Bellevue Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75K | Buy |
676
+3
| +0.4% | +$333 | 0.04% | 122 |
|
|
2025
Q1 | $75.5K | Buy |
673
+2
| +0.3% | +$224 | 0.04% | 120 |
|
|
2024
Q4 | $62K | Buy |
671
+65
| +11% | +$6.01K | 0.03% | 134 |
|
|
2024
Q3 | $50.8K | Buy |
606
+2
| +0.3% | +$168 | 0.03% | 160 |
|
|
2024
Q2 | $41.5K | Buy |
604
+4
| +0.7% | +$275 | 0.02% | 164 |
|
|
2024
Q1 | $44K | Sell |
600
-164
| -21% | -$12K | 0.03% | 163 |
|
|
2023
Q4 | $61.9K | Buy |
764
+4
| +0.5% | +$324 | 0.05% | 128 |
|
|
2023
Q3 | $57K | Sell |
760
-222
| -23% | -$16.7K | 0.04% | 124 |
|
|
2023
Q2 | $75.7K | Buy |
982
+3
| +0.3% | +$231 | 0.05% | 107 |
|
|
2023
Q1 | $81.2K | Buy |
979
+3
| +0.3% | +$249 | 0.06% | 101 |
|
|
2022
Q4 | $82.9K | Hold |
976
| – | – | 0.06% | 107 |
|
|
2022
Q3 | $60K | Buy |
976
+8
| +0.8% | +$492 | 0.05% | 135 |
|
|
2022
Q2 | $60K | Buy |
968
+5
| +0.5% | +$310 | 0.04% | 140 |
|
|
2022
Q1 | $58K | Buy |
963
+2
| +0.2% | +$120 | 0.04% | 154 |
|
|
2021
Q4 | $70K | Sell |
961
-171
| -15% | -$12.5K | 0.04% | 144 |
|
|
2021
Q3 | $80K | Buy |
1,132
+78
| +7% | +$5.51K | 0.05% | 135 |
|
|
2021
Q2 | $73K | Buy |
1,054
+2
| +0.2% | +$139 | 0.04% | 149 |
|
|
2021
Q1 | $68K | Hold |
1,052
| – | – | 0.04% | 151 |
|
|
2020
Q4 | $71K | Buy |
1,052
+52
| +5% | +$3.51K | 0.04% | 146 |
|
|
2020
Q3 | $63K | Buy |
1,000
+250
| +33% | +$15.8K | 0.04% | 139 |
|
|
2020
Q2 | $58K | Buy |
750
+75
| +11% | +$5.8K | 0.06% | 146 |
|
|
2020
Q1 | $53K | Buy |
675
+50
| +8% | +$3.93K | 0.06% | 160 |
|
|
2019
Q4 | $41K | Buy |
+625
| New | +$41K | 0.03% | 169 |
|